Context Therapeutics Correlations

CNTX Stock

USD 0.77 0 0.26%

The current 90-days correlation between Context Therapeutics and Acumen Pharmaceuticals is 0.33 (i.e., Weak diversification). The correlation of Context Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Context Therapeutics Correlation With Market

Weak diversification

The correlation between Context Therapeutics and DJI is 0.31 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Context Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Context Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Context Stock please use our How to Invest in Context Therapeutics guide.

Moving together with Context Stock

0.69	DSGN	Design Therapeutics	Pair Corr
0.8	EYEN	Eyenovia	Pair Corr
0.88	CGC	Canopy Growth Corp	Pair Corr
0.62	MRK	Merck Company	Pair Corr
0.65	INBX	Inhibrx Symbol Change	Pair Corr
0.9	ISPC	iSpecimen	Pair Corr
0.61	ITOS	Iteos Therapeutics	Pair Corr
0.71	LFCR	Lifecore Biomedical	Pair Corr
0.84	MREO	Mereo BioPharma Group	Pair Corr
0.82	ANNX	Annexon Earnings Call This Week	Pair Corr
0.79	ASMB	Assembly Biosciences Earnings Call This Week	Pair Corr
0.68	BLUE	Bluebird bio Earnings Call This Week	Pair Corr
0.79	TLRY	Tilray Inc	Pair Corr
0.8	CLDX	Celldex Therapeutics	Pair Corr
0.87	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.8	CRVS	Corvus Pharmaceuticals	Pair Corr

Moving against Context Stock

0.4	OPT	Opthea	Pair Corr
0.83	NVRO	Nevro Corp	Pair Corr
0.82	FNA	Paragon 28	Pair Corr
0.74	LUCD	Lucid Diagnostics	Pair Corr
0.73	CPIX	Cumberland Pharmaceuticals	Pair Corr
0.7	NYXH	Nyxoah	Pair Corr
0.68	CMRX	Chimerix	Pair Corr
0.53	CYTH	Cyclo Therapeutics	Pair Corr
0.51	INMD	InMode	Pair Corr
0.49	KIDS	Orthopediatrics Corp	Pair Corr
0.49	LUNG	Pulmonx Corp	Pair Corr

Related Correlations Analysis

	TERN	AMLX	ABOS	INZY	XFOR	SPRO	BOLT	CHRS	GRCL	NLTX
TERN		0.68	0.95	0.93	0.83	0.9	0.75	0.9	0.0	0.0	TERN
AMLX	0.68		0.63	0.71	0.5	0.56	0.3	0.48	0.0	0.0	AMLX
ABOS	0.95	0.63		0.87	0.82	0.91	0.81	0.9	0.0	0.0	ABOS
INZY	0.93	0.71	0.87		0.81	0.89	0.7	0.84	0.0	0.0	INZY
XFOR	0.83	0.5	0.82	0.81		0.76	0.8	0.76	0.0	0.0	XFOR
SPRO	0.9	0.56	0.91	0.89	0.76		0.83	0.91	0.0	0.0	SPRO
BOLT	0.75	0.3	0.81	0.7	0.8	0.83		0.81	0.0	0.0	BOLT
CHRS	0.9	0.48	0.9	0.84	0.76	0.91	0.81		0.0	0.0	CHRS
GRCL	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	GRCL
NLTX	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		NLTX
	TERN	AMLX	ABOS	INZY	XFOR	SPRO	BOLT	CHRS	GRCL	NLTX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ABOS	+ 0.95	TERN
INZY	+ 0.93	TERN
SPRO	+ 0.91	ABOS
CHRS	+ 0.91	SPRO
SPRO	+ 0.9	TERN
CHRS	+ 0.9	TERN

High negative correlations

NLTX	- 0.0	GRCL
NLTX	- 0.0	CHRS
GRCL	- 0.0	CHRS
NLTX	- 0.0	BOLT
GRCL	- 0.0	BOLT
NLTX	- 0.0	SPRO

Risk-Adjusted Indicators

There is a big difference between Context Stock performing well and Context Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Context Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Treynor Ratio	Potential Upside	Value @Risk	Maximum Drawdown
TERN	2.99	(0.99)	(1.29)	4.94	(6.98)	19.13
AMLX	3.72	(0.05)	(0.11)	7.20	(9.09)	21.45
ABOS	2.97	(0.69)	(0.63)	6.57	(7.09)	19.77
INZY	4.06	(1.42)	(0.90)	6.82	(9.17)	36.29
XFOR	6.40	(0.54)	(1.69)	11.67	(13.51)	68.45
SPRO	2.57	(0.56)	3.53	4.85	(6.25)	21.98
BOLT	2.62	(0.22)	(1.22)	5.08	(6.45)	17.46
CHRS	4.02	(0.81)	1.65	7.48	(9.09)	31.16
GRCL	0.00	0.00	0.00	0.00	0.00	0.00
NLTX	0.00	0.00	0.00	0.00	0.00	0.00

Context Therapeutics Corporate Management

Alex Esq	Chief Secretary	Profile
Martin Lehr	President, CoFounder	Profile
Christopher MBA	Senior Operations	Profile
Tarek MD	Chief Officer	Profile
Elizabeth CPA	Controller	Profile
Jennifer MinaiAzary	CFO Treasurer	Profile
Claudio MD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC